BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Life Raft Group - ECPv6.17.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Life Raft Group
X-ORIGINAL-URL:https://liferaftgroup.org
X-WR-CALDESC:Events for The Life Raft Group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190808T140000
DTEND;TZID=America/New_York:20190808T150000
DTSTAMP:20190814T174529Z
CREATED:20190711T153122Z
LAST-MODIFIED:20190814T174529Z
UID:10000035-1565272800-1565276400@liferaftgroup.org
SUMMARY:LRG Webcast Series: When to Consider Surgery
DESCRIPTION:This webcast will address the issues surrounding the decision to have an operation. Most GIST patients will see a surgeon at some point during their treatment. The decision to consider surgical options depends on a number of factors such as tumor location\, tumor size\, tumor number\, response to drug therapy\, and risk of recurrence. \nDr. Jason Sicklick from Moores Cancer Center at the University of California San Diego will discuss situations when surgical management may be appropriate for managing localized\, regionally advanced and metastatic GIST. \n\nListen To The Webcast\n\nThere will be a 15 minute Q & A at the end of the presentation.\n \nAbout the Presenter:\nJason K. Sicklick\, MD\, FACS\, is an Associate Professor of Surgery\, Division of Surgical Oncology; and Co-Director\, Biorepository and Tissue Technology Shared Resource\, Moores Cancer Center at the University of California\, San Diego\, UC San Diego Health Sciences. \n  \n  \n  \n\nTechnical Tips to Join Meeting:\n\nThis is a web-only meeting\, accessed only by your internet connection. Participants are encouraged to use the web link automatically provided after registration and to use computer speakers (and/or headsets if available) to hear the audio portion of the meeting. Please log in at least ten minutes prior to the start of the webinar.\nPlease ensure you have an updated version of Adobe Flash Player (Google Chrome has Flash built-in).\nIf you are using a mobile device or tablet\, in order to view and hear the conference\, download the ReadyTalk App from your App store.\n\n\nDisclaimer:\nWe cannot provide individual medical advice during this webcast. Information provided in this webcast is not intended as a substitute for your physician’s guidance and care.
URL:https://liferaftgroup.org/event/lrg-webcast-series-when-to-consider-surgery/
LOCATION:NJ
CATEGORIES:Events
ATTACH;FMTTYPE=image/jpeg:https://liferaftgroup.org/wp-content/uploads/2019/07/sicklick-surgery-webcast.jpg
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190820T160000
DTEND;TZID=America/New_York:20190820T170000
DTSTAMP:20190906T143456Z
CREATED:20190812T150929Z
LAST-MODIFIED:20190906T143456Z
UID:10000038-1566316800-1566320400@liferaftgroup.org
SUMMARY:Informational Webinar on Avapritinib
DESCRIPTION:Informational Webinar on Avapritinib Clinical Trial Program in GIST – presented by Blueprint Medicines\n\nRECAP HERE\n\nTuesday\, August 20\, Blueprint Medicines is working with The Life Raft Group and GIST Support International to host a webinar providing a data update from the registration-enabling NAVIGATOR trial of the investigational treatment avapritinib in patients with PDGFRA Exon 18 mutant GIST and fourth-line GIST. These data were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 1\, 2019. Please see here for the press release summarizing the data and the slides presented at ASCO. \nThe webinar will be held on August 20th beginning at 4:00 p.m.\, Eastern Time (1:00 p.m.\, Pacific Time).  Maria Roche\, Senior Medical Director at Blueprint Medicines\, will provide an overview of the data presented at ASCO and an update on ongoing or planned studies in multiple lines of GIST treatment. We invite patients with GIST and their families to participate in this informational webinar – see details to access the webinar below. \nPlease submit suggested questions that you would like to be addressed during the webinar to patients@blueprintmedicines.com by Thursday\, August 15th.
URL:https://liferaftgroup.org/event/informational-webinar-on-avapritinib/
LOCATION:NJ
CATEGORIES:Research,Webcast
ATTACH;FMTTYPE=image/png:https://liferaftgroup.org/wp-content/uploads/2019/08/blueprint-medicines-event.png
END:VEVENT
END:VCALENDAR